Skip to main content

Table 1 Patient characteristics

From: Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation

Characteristic

No. (%) (n = 60)

Gender

 

 Male

38 (63.3)

 Female

22 (36.7)

Age group

 

 < 6 years

26 (43.3)

 6-11 years

34 (56.7)

Donor

 

 MUD

20 (33.3)

 MMFD

27 (45.0)

 MFD

13 (21.7)

Primary diagnosis

 

 ALL

6 (10.0)

 ALL relapse

11 (18.3)

 AML

2 (3.3)

 AML relapse

2 (3.3)

 Biphenotypic leukemia

1 (1.7)

 CML

2 (3.3)

 JMML

3 (5.0)

 MDS

5 (8.3)

 Solid tumors

7 (11.7)

 Aplastic anemia

9 (15.0)

 Neurometabolic diseases

4 (6.7)

 Immunologic diseases

6 (10.0)

 Chediak-Higashi-syndrome

1 (1.7)

 Kostmann disease

1 (1.7)

Graft-versus-Host-Disease

 

 Grade I

23 (38.3)

 Grade II

3 (5.0)

 Grade III

4 (6.7)

 Grade IV

2 (3.3)

 Chronic limited

2 (3.3)

 Chronic extensive

1 (1.7)

  1. Abbreviation: ALL, acute lymphoblastic leukemia; AML, acute myelogenous leukemia; CML, chronic myeloid leukemia; JMML, juvenile myelomonocytic leukemia; MDS, myelodysplastic syndromes, MFD, matched family donor; MMFD, mismatched family donor; MUD, matched unrelated donor.